Supporting the

Neuroendocrine Cancer Community

Neuroendocrine Cancer information sent to over 45,000 GPs

Apr 6, 2023

Neuroendocrine Cancer is a rare and complex form of cancer that affects the neuroendocrine system, which is responsible for producing hormones that regulate various bodily functions. While relatively uncommon, it can be challenging to diagnose, often leading to significant delays in treatment.

To address this issue, we have launched a new campaign called “Spotlight on Neuroendocrine Cancer.” The campaign aims to educate healthcare professionals about neuroendocrine cancer and raise awareness of this type of cancer, ultimately improving the patient experience.

As part of this initiative, we collaborated with Red Whale to distribute our “Overview of Neuroendocrine Cancer” GP information guide to 45,000 GPs in the UK. The guide provides essential information on neuroendocrine cancer, including clinical presentation, symptoms, and common differential diagnoses. It also covers useful investigations to diagnose the disease and the psychosocial impact of neuroendocrine cancer.

The majority of cancer patients are referred through their GP, making it vital to educate healthcare professionals about neuroendocrine cancer. Statistics show that individuals visit their GPs an average of 11 times before receiving a diagnosis of neuroendocrine cancer. By increasing awareness and understanding of this cancer, patients will receive timely and accurate diagnoses, leading to better treatment outcomes.

The “Spotlight on Neuroendocrine Cancer” campaign aims to ensure that all neuroendocrine cancer patients have access to the same all-inclusive, joined-up care. This means that patients can see the right healthcare professional at the right time and in the right place. By providing relevant and easy-to-understand education about neuroendocrine cancer, healthcare professionals can improve patient outcomes and provide better support for those with this rare form of cancer.

To learn more about our “Spotlight on Neuroendocrine Cancer” campaign, visit our website: